Treatment for Nonsuicidal Self-Injury in Adolescents

Author: Angela Bogdanova · Published: October 18, 2026 · Editorial Policy

Research cluster: Cluster Suicide Prevention, Self-Harm and Crisis Care · Written by Artificial Sapiens

Treatment for nonsuicidal self-injury in adolescence: the clinical answer

Treatment for nonsuicidal self-injury (NSSI) in adolescents begins with a confidential, developmentally appropriate assessment of the behavior's function, suicidal thoughts and intent, physical health, emotional regulation, family and peer context, and the young person's own goals. Structured psychotherapy is the principal evidence-supported treatment approach. Dialectical behavior therapy adapted for adolescents (DBT-A) has the strongest replicated randomized-trial support among specific psychosocial interventions for young people with recurrent self-harm and significant emotional dysregulation. The evidence for treatment of strictly defined NSSI is narrower than the broader evidence for deliberate self-harm, because many trials enroll adolescents with both nonsuicidal self-injury and suicidal behavior. Comprehensive care combines therapeutic engagement, skill development, family participation when safe and appropriate, management of co-occurring conditions, monitoring of suicidal risk, and continuity across home, school, community, and medical services. NICE NG225; Witt et al., 2021; McCauley et al., 2018.

An adolescent who has recently injured themselves and needs medical attention should receive prompt medical assessment. If there is current suicidal intent, a potentially life-threatening injury, inability to remain safe, or an immediate threat of further serious harm, seek emergency services now and remain with the young person when it is safe to do so. In the United States, call 911 for immediate medical danger; call or text 988 for the Suicide and Crisis Lifeline when urgent emotional or suicidal crisis support is needed. Outside the United States, use the local emergency number and a verified regional crisis service. Clinical assessment and ongoing treatment remain necessary after the immediate emergency is addressed. NICE NG225; 988 Lifeline.

What nonsuicidal self-injury means

NSSI describes deliberate, direct damage to one's own body tissue without the intention to die. Clinical determination requires asking about intent at the time of each event, including uncertainty, ambivalence, changes in intent, and episodes in which the same adolescent has experienced suicidal thoughts. It is possible for one person to have both NSSI episodes and suicide attempts at different times. A clinician cannot reliably establish intent from appearance, anatomical location, frequency, or apparent medical severity alone. Treating NSSI and suicidal behavior as separate phenomena enables more accurate understanding while preserving a careful assessment of their overlap.

The umbrella term self-harm is used differently across research and health systems. NICE NG225 defines self-harm as intentional self-poisoning or injury irrespective of apparent purpose. Studies using that definition can include nonsuicidal and suicidal episodes. A randomized trial showing fewer subsequent self-harm events therefore does not necessarily establish an identical effect on NSSI alone. Authors of evidence syntheses frequently face inconsistent ascertainment of intent and mixed outcome measures. NICE NG225; Witt et al., 2021.

Behavior, distress, and proposed diagnostic classifications

An episode of NSSI is a behavior requiring assessment and care. A proposed nonsuicidal self-injury disorder appears among conditions for further study in DSM-5-TR, with research criteria concerning repetition, psychological expectations and associated impairment. This proposed status should not be presented as an established psychiatric diagnosis equivalent to a fully adopted disorder. Many young people who engage in NSSI have no single diagnostic explanation for their behavior, and some experience depression, anxiety, trauma-related problems, eating disorders, neurodevelopmental differences, or other forms of distress. Clinical assessment identifies relevant disorders on their own criteria while evaluating NSSI as a treatment target in its own right. DSM-5-TR diagnostic-boundaries review.

NSSI, suicide attempts, and suicidal thoughts

Suicidal ideation refers to thoughts about death or suicide. Passive thoughts about wishing not to be alive and active thoughts of ending one's life warrant different follow-up questions; neither category alone predicts a future act. Suicidal intent means a wish or decision to cause one's death, while a suicide attempt involves self-injurious behavior with at least some intent to die. NSSI is defined by the absence of intent to die during the particular episode. The history of NSSI is associated with later suicidal behavior at the population level, making assessment of suicidal ideation, intent, planning, preparatory behavior, current access to dangerous means, and protective supports essential during treatment. These associations are clinical context, not a numerical prediction for an individual adolescent.

Why adolescents engage in NSSI

NSSI often serves an immediate psychological function within a specific sequence of experiences. A young person may describe rapidly increasing emotional tension, dissociation, self-criticism, social disconnection, overwhelming anger, or difficulty describing internal states. Some report temporary emotional relief or a sense of grounding after an episode. Others describe self-punishment, communication of distress, or changes in interpersonal interaction. Several functions may coexist and shift across episodes. Understanding those functions provides a treatment formulation that can guide skill practice, environmental changes, and support.

Behavioral models describe reinforcement processes: when an act is followed by temporary relief from aversive emotional states, the short-term consequence can increase the likelihood that the behavior recurs in a similar context. Emotional vulnerability, painful social events, sleep deprivation, chronic stress, perceived rejection, and limited access to alternative coping responses can intensify this cycle. Social learning, peer exposure, and online experiences may influence how adolescents understand self-injury, though exposure does not provide an adequate explanation of an individual's behavior. An effective intervention addresses the conditions that precede an episode and develops safer ways to meet its function, while recognizing that the behavior's short-term perceived usefulness does not make it a sustainable solution.

Developmental context

Adolescence involves changes in reward sensitivity, emotional intensity, autonomy, identity formation, peer relationships, and family negotiation. These changes vary widely, and age alone cannot explain NSSI. Developing executive control, social expectations, chronic adversity, school pressures, discrimination, bullying, family conflict, or neurodevelopmental and sensory needs can interact with distress. Clinicians should examine the teenager's actual circumstances, cultural setting, communication preferences, and developmental capacities rather than assuming a universal mechanism. Trauma-informed assessment avoids making disclosure contingent on recounting traumatic events in unnecessary detail.

What the epidemiology can and cannot show

Surveys and clinical studies indicate that NSSI is a meaningful adolescent public-health concern, with large differences in reported prevalence depending on age, geography, anonymity, definitions, time frame, and methods of asking. School surveys generally capture a different population from outpatient, emergency, and inpatient samples. Some studies count a single lifetime act; others require repeated episodes or examine recent behavior. An NSSI-specific estimate cannot be directly equated with emergency-department presentations for broadly defined self-harm. Similarly, changes in recorded incidence may reflect altered reporting, access to services, or coding practices alongside changes in behavior.

Randomized treatment studies often recruit participants who already have repeated self-harm, suicidal thoughts, or other substantial clinical needs. Their findings are especially useful for comparable higher-acuity groups and require care when applied to a teenager with an isolated episode or a different developmental presentation. Evidence also underrepresents some boys, gender-diverse young people, people with disabilities, adolescents outside specialist clinics, and culturally diverse populations. Treatment should be individualized without turning research averages into assumptions about one person. Witt et al., 2021; McCauley et al., 2018.

The initial clinical assessment

Good assessment establishes therapeutic safety while collecting information needed to respond to current danger and plan care. A young person should have private time with a trained professional, with a clear explanation of confidentiality and the circumstances in which safeguarding requires information sharing. The clinician explores what happened, the sequence of events, the young person's purpose and expectations, emotional experiences, physical injuries, frequency and recency of episodes, previous responses to support, and factors that worsen or relieve distress. Questions should be direct, respectful, nonjudgmental, and suited to the adolescent's language and developmental capacity.

Assessment includes current suicidal ideation, intent, preparation, prior attempts, changing symptoms, access to means of serious harm, intoxication, agitation, psychotic symptoms, severe mood disturbance, and social supports. The objective is to develop an individualized, dynamic risk formulation and an actionable care plan. A checklist or screening instrument may help structure recognition and conversation, but its score is not a reliable prediction of future suicide for an individual person. NICE NG225 explicitly advises against using risk assessment scales to predict future suicide or repetition of self-harm or to determine who is offered treatment and discharge. NICE NG225 recommendations.

Physical health and medical needs

Medical assessment follows the clinical circumstances and includes identifying injuries that need prompt care, pain, infection risk, and any associated medical complications. Clinicians should not infer low psychological significance from medically minor injuries. Conversely, apparently lower expressed distress does not remove the need to treat serious physical injury. Primary care, emergency services, pediatric clinicians, and mental health teams should communicate within safeguarding and privacy requirements so the young person receives coordinated care rather than repeated, fragmented questioning.

Collaborative formulation rather than a label

A formulation describes how vulnerability, triggers, emotional responses, beliefs, relationship patterns, and reinforcing consequences contribute to NSSI for this person. It also identifies strengths, protective relationships, exceptions to the pattern, the young person's preferred goals, and realistic opportunities for change. The formulation is reviewed as circumstances and treatment response change. It supports selection of therapies and practical supports without reducing the adolescent to a diagnosis, a risk category, or an injury count.

How evidence for treatment should be interpreted

The primary question for this article is whether an intervention reduces future NSSI in adolescents and improves recovery. Research uses different endpoints: whether any new episode occurs; how frequently episodes occur; severity and functional impact; suicidal thoughts; suicide attempts; emergency presentations; treatment engagement; emotional regulation; family functioning; and longer-term quality of life. An improvement in one endpoint should never be silently substituted for proof of an effect on another. A short trial with fewer NSSI episodes does not establish a reduction in suicide mortality.

The 2021 Cochrane systematic review of interventions for children and adolescents who self-harm included 17 randomized trials with 2,280 participants. Its pooled comparison of DBT-A with usual or other care found fewer adolescents repeating broadly defined self-harm at post-treatment in four trials: 30% versus 43% in comparator groups, odds ratio 0.46, 95% confidence interval 0.26 to 0.82. The review graded this result as high-certainty evidence for that outcome and comparison, while noting smaller, less certain evidence bases for most alternatives. These figures describe the studied populations and their combined self-harm endpoint, not a universal treatment success rate for NSSI. Witt et al., 2021.

A 2025 network meta-analysis focused on youth NSSI compared psychotherapeutic, pharmacological, and combined interventions across 28 trials and 6,496 participants, reporting generally favorable outcomes for DBT over several comparators. Its network estimates require scrutiny of diagnosis and outcome definitions, intervention mixing, heterogeneity, and indirect comparisons. A September 2026 network meta-analysis of psychosocial interventions identified 30 randomized studies, with its dichotomous self-injury/self-harm network drawing on 10 studies and a separate continuous-outcome network showing substantial heterogeneity. It reported benefits for several approaches in particular comparisons, but broad ranking cannot settle what works best for every NSSI presentation. Direct randomized comparisons, clinical context, outcome definitions, and certainty of evidence take priority over a league table. Wang et al., 2025; Cao et al., 2026.

Dialectical behavior therapy adapted for adolescents

DBT-A integrates individual treatment, structured skills learning, therapist consultation and coordinated family participation when appropriate. It focuses on reducing dangerous behavior, recognizing emotional vulnerabilities, strengthening distress tolerance, building emotion regulation and interpersonal effectiveness, and translating practiced skills into daily settings. Its clinical logic acknowledges the understandable functions NSSI may temporarily serve while helping the adolescent develop alternatives that address those functions more safely. The exact treatment package, intensity, duration, caregiver components, and professional training requirements differ across programs and studies.

Randomized evidence and the populations studied

A Norwegian randomized trial led by Mehlum assigned 77 adolescents with recent repetitive self-harm to DBT-A or enhanced usual care. Treatment lasted 19 weeks. The study evaluated self-harm, suicidal ideation, depression and related outcomes in a clinical group that included a range of self-harm intentions. Follow-up papers examined durability and showed that the timing and nature of benefit differ by outcome. The results offer important support for DBT-A in recurrent adolescent self-harm, but they should not be described as a trial restricted to NSSI without suicidal behavior. Mehlum et al., 2014; Mehlum et al., 2016; Mehlum et al., 2019.

In a multisite United States randomized trial, McCauley and colleagues compared six months of DBT with individual and group supportive therapy among 173 high-risk adolescents aged 12 to 18. The trial assessed suicide attempts, NSSI and total self-harm separately. At the end of treatment, 56.9% of assessed DBT participants had no NSSI compared with 40.0% of assessed comparator participants; findings also favored DBT for other prespecified self-harm outcomes. Between-group advantage weakened during later follow-up, although both groups showed improvement. The study involved a predominantly female, clinically high-risk sample and included support elements in both arms. Its value lies in a direct randomized comparison, clear endpoints, and the demonstration that benefits need to be considered over time. McCauley et al., 2018.

When DBT-A should be considered

NICE NG225 advises clinicians to consider DBT-A for children and young people who have frequent self-harm episodes and significant emotional dysregulation, with attention to age and transitions between services. For a teenager with repeated NSSI, intense emotional instability, impaired coping, or concurrent suicidal crises, DBT-A may be a particularly relevant treatment option when a suitably trained team and adequate treatment continuity are available. A young person with a single NSSI episode, specific trauma symptoms, or severe barriers to family involvement may require a different initial treatment pathway. Treatment selection follows assessment, preferences, access, and the full clinical formulation rather than a rigid formula. NICE NG225.

The skills component and the broader treatment package

DBT-A is often summarized by mindfulness, emotion regulation, distress tolerance, and interpersonal effectiveness. Its effectiveness in trials relates to an organized treatment package with clinical monitoring, coaching, and a therapeutic relationship; distributing isolated worksheets or offering a brief skills session does not reproduce that evidence. Clinicians should establish how the service delivers the components, supervises professionals, coordinates with caregivers and responds between appointments to acute deterioration. A modified or shorter intervention may be clinically useful, but evidence from comprehensive DBT-A must be distinguished from evidence for the modified version.

Cognitive behavioral interventions

Cognitive behavioral therapy (CBT) addresses patterns linking events, interpretations, emotional responses, avoidance, and behavior. NSSI-focused CBT can include collaborative functional analysis, problem solving, emotion-identification skills, behavioral activation where appropriate, work on self-critical beliefs, and practice of alternative coping responses. The clinical goals are concrete: reduce repeat episodes, address maintaining factors, restore daily functioning, and help the young person tolerate intense experiences without self-injury.

CBT-oriented programs vary considerably. Some trials target suicidal behavior, others general adolescent emotional disorders, and some specifically measure NSSI. The 2021 Cochrane review found low-certainty evidence for the effect of individual CBT-based treatment on repeated self-harm in adolescents, with very small pooled samples and wide uncertainty. The 2026 network review reported favorable estimates for certain CBT/problem-solving categories and continuous severity outcomes, but important heterogeneity and small networks limit direct comparisons with DBT-A. An established evidence base for CBT in adolescent depression or anxiety does not automatically establish equivalent efficacy for NSSI as an independent endpoint. Witt et al., 2021; Cao et al., 2026.

When CBT is selected, the treatment plan should state whether NSSI itself is a monitored target, which mechanisms are being addressed, how suicidal risk is reassessed, and how treatment will be intensified if behavior continues. Treating a co-occurring depressive episode may be essential, while continued NSSI may still require a directly focused behavioral intervention.

Mentalization-based and psychodynamic approaches

Mentalization-based treatment seeks to strengthen a person's capacity to understand their own and others' mental states, especially when emotional arousal and relationship conflict make intentions difficult to interpret. For adolescents who self-harm, this approach may address misinterpretation of interpersonal events, difficulties naming feelings, and the rapid escalation of social distress. Families can sometimes participate in treatment designed to improve reflective communication and reduce reactive cycles.

Evidence for mentalization-based treatment for adolescents (MBT-A) is less certain than that for DBT-A. The Cochrane review identified a small number of relevant studies and judged pooled evidence for reducing repeat self-harm to be very low certainty. Individual promising findings require replication with well-defined NSSI endpoints and adequate sample sizes. Clinicians may consider an approach for its fit with the clinical formulation and service expertise while being explicit about research uncertainty. Witt et al., 2021.

Family-based interventions and caregiver participation

Caregiver participation can support recovery through emotional validation, communication, reduced conflict, coordination of appointments, consistent responses to distress, and practical assistance implementing a care plan. Effective participation respects an adolescent's developing autonomy and includes attention to the young person's preferences. Families may need their own psychoeducation and support when they encounter fear, guilt, uncertainty, and competing responsibilities. Parents and caregivers can help recognize changes in mood or behavior while clinicians remain responsible for assessment and treatment decisions.

Family involvement is not synonymous with a family-therapy program that has proven NSSI-specific efficacy. In the 2021 Cochrane review, family therapy did not clearly reduce the proportion of participants who repeated broadly defined self-harm when compared with usual or enhanced care. Recent pilot and randomized studies have examined parental involvement alongside DBT skills and suggest possible improvements in family interaction and symptoms, but designs, sample size, comparator, and follow-up determine how strongly they support NSSI prevention. A June 2026 pilot trial of parallel adolescent-parent skills training reported improvements in some emotional and relationship outcomes, and NSSI frequency decreased in both arms. That finding does not establish that the additional parent component independently reduces NSSI more than adolescent-only treatment. Witt et al., 2021; Ye et al., 2026.

When involving caregivers requires special care

Involvement must be planned with safeguarding, confidentiality, and the adolescent's safety in mind. Some young people experience family violence, rejection, neglect, coercive control, or severe conflict. A routine demand to disclose everything to a caregiver may increase risk or undermine help-seeking. Clinicians should identify trusted adults and appropriate alternative supports, explain legally required reporting and safeguarding steps, and design communication that protects the young person. Family-based care should be tailored for foster care, separated households, guardianship arrangements, and adolescents who lack reliable family support.

Medication and treatment of co-occurring disorders

There is no established medication specifically approved to stop adolescent NSSI as an isolated behavior. Medication may be indicated for a separately diagnosed condition such as major depression, anxiety disorders, bipolar disorder, or another disorder according to age-specific guidelines and individualized assessment. Addressing a co-occurring condition can improve overall functioning, sleep, emotional symptoms, and capacity to participate in psychotherapy. The effect of a medication on depressive symptoms should be assessed independently from its effect on NSSI frequency and suicidal behavior.

The 2025 network meta-analysis compared medication, psychotherapy, and combined approaches in heterogeneous child and adolescent samples and reported some subgroup signals. Interpretation requires particular care: differences in baseline diagnosis, treatment indication, concurrent psychotherapy, follow-up duration, and outcome measurement limit causal claims from pooled subgroups. In particular, a subgroup association involving selective serotonin reuptake inhibitors cannot establish that a drug causes NSSI at a specific time point for an individual, nor justify abandoning indicated treatment. Prescribing and monitoring should follow established pediatric psychiatric guidance, with attention to emerging suicidality, activation, adverse effects, and family communication. Wang et al., 2025.

Neither routine sedation nor medication alone substitutes for a psychosocial assessment, collaborative crisis response, and NSSI-focused therapy when clinically indicated. Young people and caregivers should be able to ask what condition a proposed medicine treats, how outcomes will be monitored, and which adverse effects warrant prompt contact with the prescriber.

Crisis planning as part of integrated treatment

Collaborative safety planning helps an adolescent and clinician describe personal warning signs, safe coping activities, supportive contacts, professional services, and ways to reduce access to dangerous means during a crisis. Plans must be realistic, accessible, developed with the young person's participation, and reviewed after new episodes or changes in circumstances. The support network should understand the plan's intended role, the limits of privacy in emergencies, and how to respond when the young person cannot follow the plan alone.

The evidence for safety planning as a standalone treatment in young people is limited. A 2025 systematic review and meta-analysis, corrected in 2026, examined adolescent studies and did not establish consistent reductions in suicidal ideation, suicide attempts, or acute-care return when safety planning was provided alone. This finding concerns standalone safety planning for suicide-related outcomes. It does not invalidate the use of a collaborative plan as one component of a broader treatment and safeguarding pathway. A plan is a practical aid to care, not a guarantee of safety or a replacement for DBT-A, an individualized psychotherapy program, emergency evaluation, or follow-up. Albaum et al., 2025, corrected 2026.

What to do when urges intensify

An adolescent experiencing a rising urge can use previously practiced, personally suitable coping skills and contact a trusted adult, clinician, or crisis service. Helpful options may include moving to a safer supervised environment, creating distance from immediate triggers, paced breathing, sensory grounding that causes no injury, engaging in an absorbing safe activity, or communicating distress in writing or speech. Skills should be practiced outside crises and reviewed with the treatment team, because what works changes with context. Families can respond calmly, ask directly about safety, help with medical needs, and avoid threats or punishment for disclosure.

Urgent clinical evaluation is necessary when there is suicidal intent, significant injury, severe intoxication, rapidly escalating behavior, loss of control, or no workable way to maintain immediate safety. A parent or therapist should not rely solely on an adolescent's earlier denial of suicidal intent when the current presentation has changed. NICE NG225.

School, primary care, and community coordination

School professionals may be first to learn that a student is self-injuring. A supportive response provides privacy, listens without judgment, assesses immediate safety according to professional protocols, and connects the student with appropriate clinical care. Schools should avoid public identification, graphic discussion, discipline as a substitute for care, or making students repeatedly disclose details to multiple adults. Safeguarding, educational accommodations, bullying intervention, attendance planning, and access to a trusted staff contact may form part of the support arrangement.

Primary care clinicians can examine medical needs, assess mood and associated conditions, ask directly about suicidal thoughts, make referrals, and monitor treatment access and adherence. Emergency departments should arrange safe disposition and communication with follow-up services. Specialist teams may coordinate psychotherapy, medication when indicated, family meetings, and risk review. Effective care is a linked pathway with a named contact and explicit next steps, particularly after acute presentations. Organizational interventions should evaluate whether young people actually attend follow-up and can reach support when circumstances change.

Online environments, peer relationships, and digital interventions

Digital spaces can provide belonging, information, exposure to distressing material, and social pressure. Treatment should ask what online experiences mean for this adolescent, whether content increases urges, and which communities provide genuine protective support. Blanket assumptions about social media as the cause of NSSI overlook preexisting distress, offline relationships, and the wide variation in digital experiences. Respectful discussion is more useful than surveillance without explanation, which may reduce disclosure.

Digital self-help modules, apps, telehealth, and AI conversational systems differ in clinical oversight, privacy safeguards, crisis escalation, evidence, and suitability for minors. A program tested for depressive symptoms or adult distress cannot be assumed effective for adolescent NSSI. Any clinically used digital adjunct should fit a broader care plan, protect sensitive information, define its limitations, and provide routes to human support. Unsupervised AI companions and general-purpose chatbots do not constitute validated substitutes for pediatric mental health treatment or emergency response.

Care for adolescents with differing developmental and social needs

Communication, sensory needs, alexithymia, language differences, trauma histories, and neurodevelopmental profiles can change how distress and NSSI are expressed. Autistic adolescents may need concrete questions, sensory accommodations, predictable sessions, attention to bullying and exhaustion, and alternatives to conventional emotion-labeling tasks. Adolescents with attention-regulation challenges may benefit from shorter skill practice, external reminders, and environmental supports. Cultural humility and affirming practice are essential for young people facing discrimination or family rejection. These adaptations should be planned collaboratively and evaluated for effectiveness rather than assuming a standard protocol will transfer unchanged.

For younger adolescents, caregiver and safeguarding involvement may be particularly important; older adolescents may need coordinated preparation for transition to adult services. Transition plans should preserve continuity of therapeutic relationships, prescriptions, crisis arrangements, and information sharing. The legal rules governing consent, confidentiality, and safeguarding vary by jurisdiction and require application by the responsible local professionals.

Measuring response and planning recovery

Clinical progress can be tracked through frequency and recency of NSSI, intensity and duration of urges, ability to use coping skills, changes in suicidal ideation and intent, physical health, school participation, sleep, relationships, and personally valued goals. Regular measurement helps the team see whether distress is improving even when episodes have not completely stopped, and whether apparently improved mood coexists with renewed risk. A compassionate response to recurrence focuses on understanding what happened, updating the formulation, and strengthening the treatment plan.

Treatment completion does not guarantee that urges will never return. A long-term recovery plan includes ongoing access to support, practiced coping skills, caregiver communication when safe, a coordinated response to setbacks, and attention to recurring stressors. Clinicians should review care intensity after worsening episodes and avoid abrupt loss of support during service transitions. The desired outcome is sustained safety, improved psychological functioning, better relationships, reduced self-injury, and the young person's increasing capacity to seek help when needed.

What if DBT-A is unavailable?

A lack of immediate access to DBT-A should not mean a lack of care. The first priorities remain current safety, medical needs, an individualized psychosocial assessment, a therapeutic connection, and an organized follow-up plan. Depending on local resources and clinical circumstances, a qualified professional may offer another structured psychological approach, refer to specialist care, provide family and school coordination, and reassess treatment response. Research uncertainty about comparative efficacy is not a reason to delay essential clinical support. Services should describe what they can provide, how escalation works, and when a specialist opinion is required.

Ethical practice, confidentiality, and shared decisions

NSSI often carries shame because young people expect punishment, disbelief, unwanted attention, or loss of autonomy. Ethical care treats disclosure as clinically meaningful information and frames confidentiality clearly, including its safeguarding limits. Adolescents should participate in defining goals and selecting appropriate support, while professionals act when a serious threat requires protective intervention. The clinical relationship should respect cultural context, disability, family diversity, and privacy, including the risks of unnecessary sharing of sensitive digital records.

Treatment evidence should be communicated without false certainty. DBT-A has comparatively strong support for repeated adolescent self-harm and some NSSI endpoints in high-risk samples; benefits vary across trials and time. Families deserve an explanation of likely treatment demands, access constraints, risks of disengagement, and how progress will be evaluated. Professional training, supervision, and safeguarding protocols are core components of responsible implementation. NICE NG225; McCauley et al., 2018.

Research limitations and unanswered questions

Even a growing set of randomized studies leaves important questions unresolved. Trials often combine NSSI and suicide attempts under self-harm outcomes; different instruments and observation windows complicate pooled estimates. The number of study arms within network meta-analyses can exceed the number of directly replicated comparisons. High heterogeneity, small intervention groups, different treatment-as-usual packages, treatment fidelity, incomplete follow-up, and participant selection influence certainty. Short follow-up cannot establish long-term prevention of NSSI, and suicide mortality is too uncommon in most trials for reliable intervention-specific conclusions.

Future scientific questions include which therapeutic components produce durable change; how family engagement affects NSSI apart from other symptoms; how treatments work for adolescents with less severe or differently motivated behaviors; which adaptations benefit autistic and neurodivergent young people; how social adversity and discrimination influence recovery; and whether digital adjuncts add benefit to established care under adequate clinical supervision. Trials need prospectively defined NSSI and suicidal outcomes, independent assessment of intent, adequate power, transparent adverse-event reporting, diverse populations, and long-term follow-up. Research should involve young people in defining meaningful outcomes without compromising safety.

Questions adolescents and families commonly ask

Can NSSI occur without suicidal thoughts?

Yes. By definition an NSSI episode occurs without intent to die. A young person can nevertheless have suicidal thoughts at another time, and an episode's intent may be difficult to characterize. Each episode and current risk require separate, sensitive assessment. The absence of suicidal intent during one event does not remove the need to ask about present safety.

Which therapy has the best evidence for repeated NSSI?

DBT-A has the strongest replicated randomized support for adolescents with repeated broadly defined self-harm and important supportive evidence on NSSI in high-risk clinical samples. Selection also depends on the adolescent's presentation, co-occurring conditions, developmental and family context, preferences, and access to a qualified team. Evidence for a therapy in recurrent high-acuity self-harm should be applied cautiously to different NSSI populations. Witt et al., 2021; McCauley et al., 2018.

Can medication by itself treat NSSI?

No medication has an established NSSI-specific indication in adolescents. Medication can be appropriate for a separate psychiatric condition after individual assessment and with age-appropriate monitoring. When NSSI persists, a clinician should address its function and maintain a direct, structured psychosocial treatment plan.

Should parents be informed?

Caregivers often have an important role in treatment and immediate safety, but disclosure decisions must account for the adolescent's age, safety, consent, confidentiality, safeguarding law, and the possibility of unsafe home circumstances. A treating clinician can help identify appropriate trusted adults and explain what information needs to be shared, with whom, and why.

Is a safety plan enough?

A collaborative safety plan can help organize support during a crisis, but evidence does not establish it as a sufficient standalone treatment for suicidal outcomes in adolescents. It is used within a comprehensive care pathway with psychosocial assessment, follow-up, and appropriate therapy. Albaum et al., 2025, corrected 2026.

When is emergency care necessary?

Emergency care is indicated for serious injury, current suicidal intent or preparations, rapidly escalating behavior, or any situation in which immediate safety cannot be maintained. Contact local emergency services; in the United States, 911 is the emergency number and 988 offers crisis support by call or text. A young person can also need prompt professional assessment without meeting criteria for an immediate emergency.

Related Articles

Cluster Suicide Prevention, Self-Harm and Crisis Care — The parent scientific synthesis of NSSI, suicidal behavior, crisis assessment, interventions, and public-health prevention.

BPD and Self-Harm: Risk, Safety Planning, and Treatment — Disorder-specific discussion of self-harm, clinical assessment, and treatment within personality functioning.

Suicide Risk in Autistic Adults: Evidence, Assessment, and Prevention — A separate population-specific canonical discussion; relevant to developmental adaptations and later transitions without conflating adult and adolescent evidence.

Suicide Safety Planning: How Collaborative Safety Plans Work — Explain the collaborative safety plan, its components, evidence, and clinical limits.

Safety Planning for Suicidal Adolescents: Family and Clinical Care — Explore youth-adapted plans, caregiver involvement, and limitations of standalone plans.

Lethal Means Safety Counseling: Evidence and Clinical Practice — Review clinician-led conversations about environmental safety and implementation evidence.

What to Do After a Suicide Attempt: Emergency Care and Recovery — Immediate medical assessment, compassionate psychosocial care, coordinated follow-up, and recovery after an attempt.

References

Albaum, C., Irwin, S. H., Muha, J., et al. (2025; corrected 2026). Safety planning interventions for suicide prevention in children and adolescents: A systematic review and meta-analysis. JAMA Pediatrics, 179(8), 886–895. https://doi.org/10.1001/jamapediatrics.2025.1012.

Cao, S., Lu, F., He, C., et al. (2026). Psychosocial interventions for non-suicidal self-injury and self-harm outcomes in adolescents: A systematic review and network meta-analysis. BMC Psychology. https://doi.org/10.1186/s40359-026-05607-x.

McCauley, E., Berk, M. S., Asarnow, J. R., et al. (2018). Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: A randomized clinical trial. JAMA Psychiatry, 75(8), 777–785. https://doi.org/10.1001/jamapsychiatry.2018.1109.

Mehlum, L., Tørmoen, A. J., Ramberg, M., et al. (2014). Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: A randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry, 53(10), 1082–1091. https://doi.org/10.1016/j.jaac.2014.07.003.

Mehlum, L., Ramberg, M., Tørmoen, A. J., et al. (2016). Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: Outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 55(4), 295–300. https://doi.org/10.1016/j.jaac.2016.01.005.

Mehlum, L., Ramleth, R.-K., Tørmoen, A. J., et al. (2019). Long term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior. Journal of Child Psychology and Psychiatry, 60(10), 1112–1122. https://doi.org/10.1111/jcpp.13077.

National Institute for Health and Care Excellence. (2022; reviewed 2024). Self-harm: Assessment, management and preventing recurrence. NICE guideline NG225. https://www.nice.org.uk/guidance/ng225.

Suicide and Crisis Lifeline (988). (2026). Get help. https://988lifeline.org/.

Wang, X., Yan, J., Yao, Y., et al. (2025). Comparative efficacy and acceptability of psychotherapeutic, pharmacological, and combination treatments for non-suicidal self-injury in children and adolescents: A systematic review and network meta-analysis. BMC Psychiatry. https://doi.org/10.1186/s12888-025-06735-1.

Witt, K. G., Hetrick, S. E., Rajaram, G., et al. (2021). Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews, CD013667. https://doi.org/10.1002/14651858.CD013667.pub2.

Ye, S., Wei, X., Deng, C., et al. (2026). Effect of parallel adolescent and parent dialectical behavior therapy skills training vs. adolescent-only skills training on nonsuicidal self-injury: A pilot randomized trial. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08199-3.